Max Healthcare Institute Limited (NSE:MAXHEALTH) — Market Cap & Net Worth
Market Cap & Net Worth: Max Healthcare Institute Limited (MAXHEALTH)
Max Healthcare Institute Limited (NSE:MAXHEALTH) has a market capitalization of $10.78 Billion (Rs996.70 Billion) as of June 17, 2026. Listed on the NSE stock exchange, this India-based company holds position #2146 globally and #82 in its home market, demonstrating a 1.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Max Healthcare Institute Limited's stock price Rs1024.10 by its total outstanding shares 973243789 (973.24 Million). Review debt load of Max Healthcare Institute Limited to assess the company's total debt and financial obligations.
Max Healthcare Institute Limited Market Cap History: 2020 to 2026
Max Healthcare Institute Limited's market capitalization history from 2020 to 2026. Data shows growth from $1.47 Billion to $10.78 Billion (46.39% CAGR).
Index Memberships
Max Healthcare Institute Limited is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$110.04 Billion | 9.80% | #6 of 20 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.14 Trillion | 0.95% | #16 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.34% | #77 of 750 |
Weight: Max Healthcare Institute Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Max Healthcare Institute Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Max Healthcare Institute Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
Max Healthcare Institute Limited's market cap is 0.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.02x
Max Healthcare Institute Limited's market cap is 1.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.47 Billion | $10.59 Billion | $589.90 Million | 0.14x | 2.49x |
| 2021 | $4.65 Billion | $25.08 Billion | -$1.38 Billion | 0.19x | N/A |
| 2022 | $4.61 Billion | $39.37 Billion | $6.05 Billion | 0.12x | 0.76x |
| 2023 | $7.21 Billion | $45.63 Billion | $11.04 Billion | 0.16x | 0.65x |
| 2024 | $11.87 Billion | $54.06 Billion | $10.58 Billion | 0.22x | 1.12x |
| 2025 | $11.00 Billion | $70.28 Billion | $10.76 Billion | 0.16x | 1.02x |
Competitor Companies of MAXHEALTH by Market Capitalization
Companies near Max Healthcare Institute Limited in the global market cap rankings as of June 17, 2026.
Key companies related to Max Healthcare Institute Limited by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1003 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.53 Billion USD ( €21.84 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1333 globally with a market cap of $19.50 Billion USD ( RM77.67 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $396.93 |
| #1003 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.53 Billion | €38.77 |
| #1333 | IHH Healthcare Bhd | KLSE:5225 | $19.50 Billion | RM8.79 |
Max Healthcare Institute Limited Historical Marketcap From 2020 to 2026
Between 2020 and today, Max Healthcare Institute Limited's market cap moved from $1.47 Billion to $ 10.78 Billion, with a yearly change of 46.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs10.78 Billion | -2.01% |
| 2025 | Rs11.00 Billion | -7.36% |
| 2024 | Rs11.87 Billion | +64.68% |
| 2023 | Rs7.21 Billion | +56.38% |
| 2022 | Rs4.61 Billion | -0.76% |
| 2021 | Rs4.65 Billion | +216.02% |
| 2020 | Rs1.47 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Max Healthcare Institute Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.78 Billion USD |
| MoneyControl | $10.78 Billion USD |
| MarketWatch | $10.78 Billion USD |
| marketcap.company | $10.78 Billion USD |
| Reuters | $10.78 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Max Healthcare Institute Limited
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive s… Read more